Duchesnay, the commitment and success of a pharmaceutical company dedicated to women's health





The interactive transcript could not be loaded.


Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jan 27, 2014

Duchesnay is a Canadian success story we can all be proud of. It is the story of a pharma company who dares to constantly push the limits. It is the story of a continued commitment to the pregnant woman and the child she is bearing who are the future of our society. It is the story of a great team dedicated to clinical research to create new medications and help millions of women around the world, relieve their suffering and improve their quality of life. It is also the story of a dynamic company in full expansion who proudly boasts and exports our know-how beyond borders.

IN 1970
When Louis Boivin, President and owner of Groupe Pharmaceutique Boivin, first acquired Canadian pharmaceutical company Duchesnay, the mission of the family-run business was simply to distribute over-the-counter and prescription medications to pharmacies throughout Quebec.

However, in the late 1980s, a member of the Boivin family experienced a very difficult pregnancy that had a significant impact on her health and well-being. Although her physician had prescribed a medication to treat her condition, her pharmacist refused to fill the prescription due to a lack of reliable scientific evidence regarding the its safety for use during pregnancy.

Seeing how the lack of information about the safe use of medications in pregnancy meant that many pregnant women were suffering needlessly, the Boivin family decided to change their company’s mission. The company then shifted its focus to ensuring that pregnant women who required pharmacological treatment, whether for pre-existing or pregnancy-related conditions, had access to reliable medical information and to medications whose use had been proven safe both for them and for their unborn or newborn babies.

IN 1992
The company officially assumed its new mission with the founding of the Louis-Boivin Family Pharmaceutical Chair on Medications, Pregnancy and Lactation at the Faculty of Pharmacy at the Université de Montréal (at Sainte-Justine Hospital for Children).

Thus, Duchesnay became the first pharmaceutical company dedicated to safeguarding the health of pregnant women and their babies.

Since then, Duchesnay has devoted a significant portion of its annual budget to funding research into drugs that are safe to use during pregnancy. The company manufactures and distributes these medications and provides the medical community with the current, evidence-based data they need to prescribe the optimal pharmacotherapy to pregnant women while protecting their unborn babies.

Today, Duchesnay continues to evolve as a research-based pharmaceutical company whose primary goal is to improve women's health and quality of life during pregnancy and breastfeeding, while reducing the number of birth defects and minimizing the impact of maternal medical issues on newborns.

But Duchesnay’s commitment to women’s health does not stop at pregnancy and breastfeeding. Thus, Duchesnay has broadened its portfolio of products to offer safe and effective therapeutic options that meet the health and quality of life needs of women and their family members at different stages of their lives.

For more information about Duchesnay, visit https://www.duchesnay.com/en/

  • Category

  • Song

    • Divine Elegance3-45-19664
  • Artist

    • Mad Music
  • Album

    • Mad Music
  • Licensed to YouTube by

    • AdRev for a 3rd Party (on behalf of Mad Music (Mad Music)); AdRev Publishing, and 1 Music Rights Societies
Comments are disabled for this video.
When autoplay is enabled, a suggested video will automatically play next.

Up next

to add this to Watch Later

Add to

Loading playlists...